Abstract:The current gold standard for diagnosis of obstructive sleep apnea (OSA) is overnight in laboratory polysomnography (PSG). However, PSGs are expensive, labor-intensive, and have long wait times. An ambulatory sleep study device, the WatchPAT, has been shown to have high correlation for sleep indices measured compared with PSG (AASM, 2016). Use of the WatchPAT could potentially lead to shorter waiting times and earlier diagnosis of OSA (Lancet Resp Med 3:310–8, 2015). Our study aimed to investigate if WatchPAT reduces time to diagnosis and treatment of OSA in a tertiary healthcare setting. A secondary aim was to investigate the cost-benefit of an ambulatory sleep study.

What problem does this paper attempt to address?

This paper aims to solve the problems of high cost and long time - consuming in the diagnosis and treatment of obstructive sleep apnea (OSA). Currently, the gold standard for OSA diagnosis is an all - night polysomnography (PSG) in the laboratory, but PSG is expensive, labor - intensive and has a long waiting time. To solve these problems, researchers introduced a portable sleep monitoring device - WatchPAT, to evaluate whether it can shorten the diagnosis and treatment time of OSA and analyze its cost - effectiveness advantages. ### Research Objectives 1. **Primary Objective**: To explore whether the use of WatchPAT can reduce the diagnosis time and treatment time of OSA in tertiary hospitals. 2. **Secondary Objectives**: To compare the cost - effectiveness between portable sleep monitoring (such as WatchPAT) and traditional laboratory PSG, and to investigate the reasons for WatchPAT "failure", that is, the situation of patients who need to be converted to laboratory PSG or repeat WatchPAT tests. ### Methods - **Research Design**: Retrospective analysis of the clinical database of all patients who underwent sleep monitoring in a tertiary hospital between 2014 and 2017. - **Patient Selection**: - **Inclusion Criteria**: All patients who underwent diagnostic sleep monitoring for suspected OSA, including PSG and WatchPAT. - **Exclusion Criteria**: Exclude PSG for non - diagnostic purposes (such as split - night PSG, CPAP and BiPAP titration), diagnostic PSG for non - sleep - related breathing disorders, and sleep monitoring for postoperative follow - up. - **Data Collection**: Collect baseline characteristics (age, gender, AHI, etc.), and record the order date, completion date of sleep monitoring and the CPAP prescription date. - **Data Analysis**: Use Kaplan - Meier analysis to compare the diagnosis time and treatment time of the PSG and WatchPAT groups, use the propensity score matching method to eliminate differences in baseline characteristics, and use paired T - test / Wilcoxon signed - rank test to compare the costs of the two groups. ### Results - **Baseline Characteristics**: A total of 1,898 patients underwent diagnostic sleep monitoring, of which 1,660 (88%) underwent PSG and 238 (12%) underwent WatchPAT. - **Diagnosis Time**: The average diagnosis time in the WatchPAT group was 21 days, which was significantly shorter than 79.8 days in the PSG group (p < 0.001). - **Treatment Time**: The average time from sleep monitoring order to CPAP prescription in the WatchPAT group was 46.3 days, which was significantly shorter than 118.4 days in the PSG group (p < 0.001). - **Cost - effectiveness Analysis**: The diagnosis cost of WatchPAT was $656, which was significantly lower than $1,835.5 of PSG, saving $1,179.50 per patient. ### Conclusions Portable sleep monitoring (such as WatchPAT) is a viable option, which can shorten the diagnosis and treatment time of OSA and bring significant cost savings. Therefore, for patients suitable for portable sleep monitoring, third - party payers should consider paying for it instead of traditional laboratory PSG.

Reducing cost and time to diagnosis and treatment of obstructive sleep apnea using ambulatory sleep study: a Singapore sleep centre experience

Real-world utility of overnight oximetry for the screening of obstructive sleep apnea in children

[Evaluation of a portable device based on peripheral arterial tone in the detection of obstructive sleep apnea].

Evaluation of Watch PAT As a Diagnosing Test for Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Mandibular movement monitor provides faster, yet accurate diagnosis for obstructive sleep apnoea: A randomised controlled study

Accuracy of WatchPAT for the Diagnosis of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease

Comparison of polysomnography and the Watch-PAT in the diagnosis of obstructive sleep apnea

Early recognition and treatment of OSA in hospitalized patients and its impact on health care utilization in rural population: a real-world study

Implementation of a new healthcare model for Obstructive Sleep Apnea diagnosis by a family doctor using a simplified device(ApneaLinkTM(R)) in conjunction with the hospital sleep unit and cost study

Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial

A new telemedicine-based sleep service using WatchPAT® ONE for patients with suspected OSA: what does the patient experience?

Cost-effectiveness strategies in OSAS management: a short review

Screening for Obstructive Sleep Apnea Using a Contact-Free System Compared with Polysomnography

Healthcare resource utilisation and costs in patients with treated obstructive sleep apnea

0293 Evaluation of a Single Point of Contact Chest-worn HSAT with ECG-based Atrial Fibrillation Detection

Assessment of Patient Journey Metrics for Users of a Digital Obstructive Sleep Apnea Program: Single-Arm Feasibility Pilot Study

Automatic monitoring of obstructive sleep apnea based on multi-modal signals by phone and smartwatch

Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea

[Detecting of Obstructive Sleep Apnea Hypopnea Syndrome Using a Multi-Parameter Pressure Sensitive Sleep Monitor].

Feasibility Study of Telemedicine Model for Diagnosis and Treatment of Patients with Obstructive Sleep Apnea Hypopnea Syndrome in China

Application study of apnea-hypopnea duration for assessing adult obstructive sleep apnea